BridgeBio Pharma Inc
NASDAQ:BBIO
BridgeBio Pharma Inc
NASDAQ:BBIO
Price:
28.01 USD
-2.91%
Market Closed
Updated:
Jun 1, 2024
BridgeBio Pharma Inc
Change in Working Capital
|
BridgeBio Pharma Inc
Change in Working Capital Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
Change in Working Capital
-$161.8m
|
CAGR 3-Years
-171%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is BridgeBio Pharma Inc's Change in Working Capital?
Change in Working Capital
-161.8m
USD
-161.8m
USD
Based on the financial report for Mar 31, 2024, BridgeBio Pharma Inc's Change in Working Capital amounts to -161.8m USD.
What is BridgeBio Pharma Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
-171%
-171%
The average annual Change in Working Capital growth rates for BridgeBio Pharma Inc have been -171% over the past three years .
You don't have any saved screeners yet
